NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









CF AMR Syndicate

CF AMR Syndicate

United Kingdomcfamr.org.uk

Overview

CF AMR Syndicate is a cross-sector initiative managed by Medicines Discovery Catapult, Cystic Fibrosis Trust, and LifeArc that accelerates the development of antimicrobials and diagnostics for cystic fibrosis by providing scientific expertise, resources, and collaborative funding.

Year Founded

2019

Portfolio Companies

3

Investments

CF AMR Syndicate investments
CompanyDateStageLead
Glox TherapeuticsJan 2025GrantCo-investor
Rostra TherapeuticsNov 2024GrantCo-investor
Oxford Drug DesignSep 2024GrantCo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersUnited Kingdom
Year Founded2019

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.